Raisio group and the benecol case

Case Analysis Raisio Group And The Benecol Essay

Retrieved September 16,from http: Because there are only a handful of companies that can create products with plant stanol ester, Benecol is a leader in its innovation for the technology.

Its stanol ester was used only in its own branded margarine, Benecol, which was produced in its own factories and marketed and distributed through its own sales and distribution system. ChichesterWest Sussex: In addition to the medicine options, there were also many natural additives such as fish oil and flax seed oil in the market.

Explanation of Relevant Concepts, Theories and Applications Derived from Course Materials When Raisio first realized that they had a great technology on their hands of producing plant stanol ester, they immediately began to create a detailed strategy development plan.

Use the order calculator below and get ordering with accurateessays. Aside from direct competitors, there were also many competitors in the ways to reduce cholesterol. Hey have a great reputation and have had numbers of success with trials and food authority exams to show that the plant stanol ester does indeed lower cholesterol.

In European Union, it was possible to go through fast-track approval, as it had already been marketed in Finland. In You can place an order similar to this with us.

Raisio Group and the Benecol Launch Introduction In this detailed case study, I endeavored to address the potential opportunities and threats facing Raisio group.

Benecol innovation

However, introducing Benecol as food into the market would prove to be a lengthy process. The profit margin was very low, only 4. This item would be a big hit with consumers that are weary about taking pills adding a powder component to food.

This strategy enabled Raisio to have control over the technology, reduce transactions costs of market contracts and maintain superior coordination through the value chain, but it failed in meeting market demand home and broad due to limited production capacity and limited supply of raw material.

It has been out since September ofyet the advertising on it seems to lack. By using a differentiation advantage which singled them out in a very specific market foods that lower cholesterol they were able to put plans in place to guarantee the success of the product.

Benecol also faced numerous competitors, such as Unilever, who also believed they had found a way to incorporate plant stanol into its foods Grant, Benecol has become a successful additive to multiple product lines due to its unique ingredient of plant stanol ester.

Conclusion Benecol seems to be a healthy alternative to taking a prescription when it comes to lowering cholesterol. If they can continue to market well and reach out to those who are health conscience and will buy their products, Benecol has no reason to believe that it will be in decline in its life cycle anytime soon.

All of these alternatives were FDA approved pills that worked by slowing down the production of cholesterol. The process of innovation and competition is also very important in the position that Benecol is in its life cycle. But the product was single, not diversified. Raisio, up untilproduced much of the plant stanol it needed and was self-sufficient in its exploitation of stanol ester technology Grant, Contemporary Strategy Analysis and Cases 7th Revised edition ed.

Because Big Pharma control much of the health claim disputes in the field, Benecol may one day be told it actually does not have enough proof to lower cholesterol. The product began with short production runs, with limited specialized distribution channels in Once Raisio wants to buy it back, the established brand would be value-added for Raisio, like what many international companies have done to enter a new market with complicated regulations and laws, different marketing channels and culture, etc.

Through this partnership, Benecol has maintained its position well within a very diverse group of products. More and more people are becoming fans of foods that claim to lower cholesterol.

Benecol then chose to market the item without health claims, until the FDA approved the item in Grant, No detailed recommendation for those two units would be made due to limited information.

Raisio Group

Benecol may need to reorganize some of its units to become cost effective and to lower some of its overhead spending. As mentioned above, this technology was the key to its success. Two important provision should include 1 all products should be under the brand of Benecol to ensure the increase of the brand value.

Raisio put systems in place and established technology to make it one of the few companies that could produce its own plant stanol ester. A growing array of cholesterol-reducing drugs was available on the market. According to the case, it would be exclusive partnership.

There were other statins such as Zocor and an atorvastin named Lipitor Grant, The FDA in turn would not agree with this argument. Raisio was undergoing a lot of pressure in its industry from the fierce competition and therefore needed a quick market penetration.Raisio Group and the Benecol Launch Case Analysis Park University Benecol was launched in by the company Raisio in Finland (“Benecol,” ).Benecol has become a successful additive to multiple product lines due to its unique ingredient of plant stanol ester.

The ingredient has been proven to reduce cholesterol levels and can easily be added to any food (Grant, ). Raisio Group and the Benecol Launch Case Analysis Park University Benecol was launched in by the company Raisio in Finland (“Benecol,” ).

Raisio Group and the Benecol Launch Introduction In this detailed case study, I endeavored to address the potential opportunities and threats facing Raisio group.

Raisio Group and the Benecol Launch Case Analysis

Benecol was launched in by the company Raisio in Finland (“Benecol,” ). Benecol has become a successful additive to multiple product lines due to. Benecol’s success was due to Raisio’s strategy to enter foreign markets. Synopsis of the Case Plant stanol ester, which was determined to lower cholesterol levels, is.

Raisio Group starts statutory cooperation negotiations; CEO's review ; Raisio to continue the group structure renewal; Benecol innovation.

Benecol® is the expert brand within the growing, diversifying category of cholesterol-lowering products.

Today, Benecol is recognized as a global, trusted brand with a number of cholesterol-lowering.

Download
Raisio group and the benecol case
Rated 5/5 based on 1 review